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Background:  Threatened preterm labour is a common reason for medical transfer from 
remote communities, however many transferred women do not deliver preterm. A tool for 
prediction of preterm birth such as fetal fibronectin may reduce transfers and the related 
social and economic costs. 
Aim: To review the use of fetal fibronectin testing in women transferred for threatened 
preterm labour from Cape York to Cairns Hospital between 2011 and 2015 and determine the 
role testing could play in reducing transfers and associated costs. 
Materials / methods: Royal Flying Doctor Service and Cairns Hospital records were accessed 
with women transferred solely for threatened preterm labour included in the study.  Fetal 
fibronectin testing, hospital admission, outpatient stays and birth outcome data was collated 
and analysed. The National Hospital Cost Data Collection, round 19 was used to assign costs. 
Results:  Forty-seven women were included in the study however only 20 underwent fetal 
fibronectin testing.  Transfer of 30 women who had either a negative test or were not tested 
but delivered at term resulted in 41 inpatient nights and 443 excess outpatient nights, costing 
an estimated A$61,579.  Aeromedical transfers were estimated to cost a further $151,500. 
Conclusion:  Adherence to clinical guidelines and greater availability and use of fetal 
fibronectin testing in Cape York has the potential to reduce aeromedical transfers for 
threatened preterm labour.  Substantial inpatient and excess outpatient stays could be avoided 
with associated reduction in health system and social costs.  Strategies to improve adherence 
to guidelines and increase access to testing are required. 
 
 
